News
12d
Zacks Investment Research on MSNSpringWorks Gets CHMP Nod for Mirdametinib in Rare DiseaseSpringWorks Therapeutics SWTX announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human ...
BeiGene's Tevimbra gets a highly sought after recommendation.
12d
Zacks Investment Research on MSNRoche Gets CHMP Nod for Itovebi Combo in the EU for Breast CancerRoche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted ...
14don MSN
GSK plc (NYSE:GSK) has strengthened its market outlook following major regulatory milestones. The U.S. FDA’s recent approval ...
The antibiotic can no longer be used in moderate acne vulgaris, eradication of Helicobacter pylori, and prevention of ...
Fresenius Kabi (“Fresenius”) announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) had issued ...
3d
Pharmaceutical Technology on MSNEC approves Takeda ADC plus chemo for stage IIb Hodgkin’s lymphomaThe European Commission (EC) has granted approval for Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin).
11d
Zacks.com on MSNAZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder CancerAstraZeneca wins CHMP nod for Imfinzi combo in muscle-invasive bladder cancer, based on data from the phase III NIAGARA study ...
The new infusion for maple syrup urine disease is for patients who cannot have an oral or enteral branched-chain amino ...
Basel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has ...
The Committee for Medicinal Products for Human Use (CHMP) has recommended that Imfinzi be used in combination with ...
The U.S. FDA’s recent approval of Nucala for chronic obstructive pulmonary disease (COPD) and a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) for Blenrep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results